Literature DB >> 3259281

The thyroid in end-stage renal disease.

E M Kaptein1, H Quion-Verde, C J Chooljian, W W Tang, P E Friedman, H J Rodriquez, S G Massry.   

Abstract

Previous studies of patients with end-stage renal disease (ESRD) indicate that the prevalence of goiter varies from 0 to 58% while that of hypothyroidism ranges from 0 to 9.5%. In addition, altered serum thyroid hormone levels are present in euthyroid patients with ESRD and may be related to nonthyroidal disorders including malnutrition. To examine these issues further, 306 patients with ESRD were compared to 139 hospitalized patients without renal disease (control population). Goiter was present in 43% with ESRD compared to 6.7% of controls (P less than 0.001). Goiter frequency was greater (49.6%, P = 0.047) and serum parathyroid hormone levels higher (mean: 238.6 microlitersEq/ml, P less than 0.001; normal: less than 15 microlitersEq/ml) in 115 patients dialyzed for longer than 1 year than in 191 dialyzed for less than 1 year or not at all (38.7%, and 61.5 microlitersEq/ml, respectively). In addition, goiter was more common in females (50.0%) than in males (35.1%, P = 0.008) with ESRD. No significant relationships were observed between goiter frequency and age, race, diabetes mellitus, or elevated antimicrosomal antibody titers. The prevalence of primary hypothyroidism was higher in ESRD (2.6%) than in 2122 in- and out-patients (1.1%) (P = 0.024). Compared to the total group of ESRD patients, the hypothyroid patients were predominantly female (88% vs. 50%) and had a higher frequency of positive antimicrosomal antibody titers (50% vs. 6.7%, P = 0.029). The frequency of hyperthyroidism was not significantly different, being 1.0% in ESRD compared to 0.3% in the general population (P = 0.057). There was a higher frequency of reduced free T4 index values in the 287 euthyroid patients with ESRD (12.9%) than in controls (3.6%) (P = 0.002). Similarly, free T3 index values were reduced below 100 in 65.5% with ESRD compared to 33.8% of controls (P less than 0.001). In addition, serum albumin levels were lower in euthyroid patients with ESRD (3.5 g/dl, P less than 0.001) than in controls (3.8 g/dl). Serum T3 levels correlated directly with both serum albumin (r = 0.57, P less than 0.001) and transferrin (r = 0.54, P less than 0.001) levels in ESRD as well as in controls (r = 0.74, P less than 0.001, and r = 0.69, P less than 0.001, respectively).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259281     DOI: 10.1097/00005792-198805000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  29 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Prevalence and clinical characteristics of hypothyroidism in a population undergoing maintenance hemodialysis.

Authors:  Klara Paudel
Journal:  J Clin Diagn Res       Date:  2014-04-15

3.  Importance of specific reference values for evaluation of the deteriorating thyroid function in patients with end-stage renal disease on hemodialysis.

Authors:  Toru Sanai; Ken Okamura; Tomoya Kishi; Motoaki Miyazono; Yuji Ikeda; Takanari Kitazono
Journal:  J Endocrinol Invest       Date:  2014-07-05       Impact factor: 4.256

4.  Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients.

Authors:  Connie M Rhee; Steven Kim; Daniel L Gillen; Tolga Oztan; Jiaxi Wang; Rajnish Mehrotra; Sooraj Kuttykrishnan; Danh V Nguyen; Steven M Brunelli; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  J Clin Endocrinol Metab       Date:  2015-01-29       Impact factor: 5.958

5.  Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients.

Authors:  Christiaan L Meuwese; Friedo W Dekker; Bengt Lindholm; Abdul R Qureshi; Olof Heimburger; Peter Barany; Peter Stenvinkel; Juan J Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2012-01       Impact factor: 8.237

6.  Thyroid hormone levels in the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex.

Authors:  W W Tang; E M Kaptein
Journal:  West J Med       Date:  1989-12

7.  Thyroid function and morphology after a successful kidney transplantation.

Authors:  L Tauchmanovà; R Carrano; T Musella; F Orio; M Sabbatini; G Lombardi; G Fenzi; S Federico; A Colao
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

Review 8.  Thyroid dysfunction and kidney disease: An update.

Authors:  Pedro Iglesias; María Auxiliadora Bajo; Rafael Selgas; Juan José Díez
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

9.  Hypothyroidism and mortality among dialysis patients.

Authors:  Connie M Rhee; Erik K Alexander; Ishir Bhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

Review 10.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.